Trials / Unknown
UnknownNCT00414739
Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- University of Rostock · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study analysis the influence of benzalkonium chloride on the density of antigen presenting Langerhans cells. This is achieved in a double blind randomized study using in-vivo confocal microscopy to identify and quantify Langerhans cells of the human cornea in its central and peripheral part. This study design is based on observations with raised Langerhans cell density after the application of benzalkonium chloride containing eye drops in glaucoma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benzalkonium chloride |
Timeline
- First posted
- 2006-12-22
- Last updated
- 2006-12-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00414739. Inclusion in this directory is not an endorsement.